Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children’s Oncology Group Studies AREN03B2 and AREN0532

Nicholas Evageliou, Lindsay A. Renfro, James Geller, Elizabeth Perlman, John Kalapurakal, Arnold Paulino, David Dix, Meryle J. Eklund, Andrew J. Murphy, Rodrigo L.P. Romao, Peter F. Ehrlich, Carly R. Varela, Kelly Vallance, Conrad V. Fernandez, Jeffrey S. Dome, Elizabeth A. Mullen

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children’s Oncology Group Studies AREN03B2 and AREN0532'. Together they form a unique fingerprint.

Medicine & Life Sciences